The Role of the Health Insurance Industry in Perpetuating Suboptimal Pain Management (Q53049421)

10 May 2018

title

The Role of the Health Insurance Industry in Perpetuating Suboptimal Pain Management (English)

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

24 November 2024

0 references

Michael E Schatman

1 reference

10 May 2018

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21332933

24 November 2024

publication date

18 February 2011

1 reference

10 May 2018

full work available at URL

https://academic.oup.com/painmedicine/article-pdf/12/3/415/5183304/12-3-415.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21332933

http://academic.oup.com/painmedicine/article-pdf/12/3/415/5183304/12-3-415.pdf

24 November 2024

file format

Portable Document Format

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

24 November 2024

1 reference

10 May 2018

volume

1 reference

10 May 2018

issue

1 reference

10 May 2018

page(s)

415-426

1 reference

10 May 2018

Emergency department coding and billing

cites work

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

Socioeconomic status and health: a micro-level analysis of exposure and vulnerability to daily stressors

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

The metamorphosis: conversion in historical context

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

Nonprofit and for-profit medical care: shifting roles and implications for health policy

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

Health insurance and market failure since Arrow.

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

The u.s. Health care non-system, 1908-2008.

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

Quality of care in investor-owned vs not-for-profit HMOs

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

Assessments of medical care by enrollees in for-profit and nonprofit health maintenance organizations

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

24 November 2024

The end of managed care

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

Current and future developments in managed care in the United States and implications for Europe

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

The payer side: patient outcomes and cost

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

Efficacy of multidisciplinary pain treatment centers: a meta-analytic review

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

Multidisciplinary rehabilitation for chronic low back pain: systematic review

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

Clinical Effectiveness and Cost-Effectiveness of Treatments for Patients With Chronic Pain

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

Multidisciplinary bio-psycho-social rehabilitation for chronic low back pain

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

Work conditioning, work hardening and functional restoration for workers with back and neck pain

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

Long-term outcomes in multidisciplinary treatment of chronic low back pain: results of a 13-year follow-up

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

A profile of users of specialty pain clinic services: predictors of use and cost estimates

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

Evidence-based scientific data documenting the treatment and cost-effectiveness of comprehensive pain programs for chronic nonmalignant pain

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

Opioid therapy for nonspecific low back pain and the outcome of chronic work loss

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

Early opioid prescription and subsequent disability among workers with back injuries: the Disability Risk Identification Study Cohort

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

Relationship between early opioid prescribing for acute occupational low back pain and disability duration, medical costs, subsequent surgery and late opioid use.

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

Chronic use of opioids and the endocrine system

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

Opioid endocrinopathy: a clinical problem in patients with chronic pain and long-term oral opioid treatment

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

Co-morbidity and utilization of medical services by pain patients receiving opioid medications: data from an insurance claims database

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

Cost and comorbidities associated with opioid abuse in managed care and Medicaid patients in the United Stated: a comparison of two recently published studies

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

The WPI's review of Wisconsin's managed care climate for pain management: opportunities for improvement

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

Illnesses you have to fight to get: facts as forces in uncertain, emergent illnesses

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

The stigmatisation of people with chronic back pain

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

The meaning and process of pain acceptance. Perceptions of women living with arthritis and fibromyalgia

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

Stigma experienced by people with nonspecific chronic low back pain: a qualitative study.

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

Job and the stigmatization of chronic pain.

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

A prospective one-year outcome study of interdisciplinary chronic pain management: compromising its efficacy by managed care policies

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

Health reform redux: learning from experience and politics

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

A qualitative study of the barriers to chronic pain management in the ED.

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

Administrative delays and chronic disability in patients with acute occupational low back injury

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

Referral delay in back pain patients on worker's compensation

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

Delayed care and unmet needs among health care system users: when does fiduciary trust in a physician matter?

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

Assessment of satisfaction with treatment for chronic pain

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

Probing the paradox of patients' satisfaction with inadequate pain management

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

Effects of a Medicaid prior authorization policy for pregabalin

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

Effect of a prior-authorization requirement on the use of nonsteroidal antiinflammatory drugs by Medicaid patients

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

Ten-year follow-up survey of clinical neuropsychologists: part II. Private practice and economics

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

Opinions and testimony of expert witnesses and independent medical evaluators

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

Industrial rehabilitation medicine. 4. Strategies for disability management

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

Are health-care reimbursement policies a barrier to acute and cancer pain management?

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

A retrospective evaluation of the use of gabapentin and pregabalin in patients with postherpetic neuralgia in usual-care settings

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

Pregabalin and gabapentin in matched patients with peripheral neuropathic pain in routine medical practice in a primary care setting: Findings from a cost-consequences analysis in a nested case-control study

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

Cost-effectiveness analysis of pregabalin versus gabapentin in the management of neuropathic pain due to diabetic polyneuropathy or post-herpetic neuralgia

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

Sequential medication strategies for postherpetic neuralgia: a cost-effectiveness analysis

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

Analgesic therapy in postherpetic neuralgia: a quantitative systematic review

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

An 8-week, open-label trial of duloxetine for comorbid major depressive disorder and chronic headache.

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

Duloxetine for treating painful neuropathy or chronic pain

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

A double-blind, randomized, placebo-controlled study of the efficacy and safety of duloxetine for the treatment of chronic pain due to osteoarthritis of the knee

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

Maintenance of effect of duloxetine in patients with chronic low back pain: a 41-week uncontrolled, dose-blinded study

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

Duloxetine for the treatment of fibromyalgia

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

Cost-effectiveness of duloxetine versus routine treatment for U.S. patients with diabetic peripheral neuropathic pain

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

Duloxetine compliance and its association with healthcare costs among patients with diabetic peripheral neuropathic pain

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

Duloxetine reduces morphine requirements after knee replacement surgery

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

Changes in opioid use and healthcare costs among U.S. patients with diabetic peripheral neuropathic pain treated with duloxetine compared with other therapies

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy

24 November 2024

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

The effectiveness of tricyclic antidepressants on lumbar spinal stenosis

24 November 2024

100

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

Side effects of antidepressants: an overview.

24 November 2024

101

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

An update on the pharmacological management of post-herpetic neuralgia and painful diabetic neuropathy

24 November 2024

102

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

Amitriptyline vs. pregabalin in painful diabetic neuropathy: a randomized double blind clinical trial

24 November 2024

103

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

Duloxetine and other antidepressants in the treatment of patients with fibromyalgia

24 November 2024

104

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

Behavioral Monitoring and Urine Toxicology Testing in Patients Receiving Long-Term Opioid Therapy

24 November 2024

105

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

Does random urine drug testing reduce illicit drug use in chronic pain patients receiving opioids?

24 November 2024

107

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

The opioid renewal clinic: a primary care, managed approach to opioid therapy in chronic pain patients at risk for substance abuse

24 November 2024

109

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

High rates of inappropriate drug use in the chronic pain population

24 November 2024

110

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

Why is urine drug testing not used more often in practice?

24 November 2024

113

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

NCCN Oncology Risk Evaluation and Mitigation Strategies White Paper: Recommendations for Stakeholders

24 November 2024

114

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

Problems with insurance-based research on chronic pain

24 November 2024

115

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

Arthritis and the role of the physician in nonmalignant pain and disability

24 November 2024

117

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

Evidence-based coverage policy

24 November 2024

118

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

Social influences on the concept of fibromyalgia

24 November 2024

119

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

Fibromyalgia syndrome: approach to management.

24 November 2024

120

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

Psychophysical and neurochemical abnormalities of pain processing in fibromyalgia.

24 November 2024

121

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

Fibromyalgia coverage uneven despite recent drug approvals

24 November 2024

122

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

The commodification of medical and health care: the moral consequences of a paradigm shift from a professional to a market ethic

24 November 2024

125

1 reference

https://api.crossref.org/works/10.1111/J.1526-4637.2011.01061.X

24 November 2024

Identifiers

1 reference

10 May 2018

1 reference

10 May 2018